Smith & Nephew (SNN) Operating Leases (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Operating Leases of $216.0 million for Q4 2025, up 10.2% year-on-year from $196.0 million in Q4 2024, and up 10.2% on a QoQ basis from $196.0 million in Q4 2024.
Smith & Nephew (SNN) Operating Leases (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Operating Leases for 11 consecutive years, with $216.0 million the latest figure, recorded in Q4 2025.
- Quarterly Operating Leases rose 10.2% year-over-year to $216.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $216.0 million (up 10.2% YoY) and the FY2025 annual result came in at $216.0 million, up 10.2% from the prior year.
- Operating Leases climbed to $216.0 million in Q4 2025 per SNN's latest filing, from $196.0 million in the prior quarter.
- Over the last five years, Operating Leases for SNN reached as high as $216.0 million in Q4 2025 and fell as low as $141.0 million in Q4 2021.
- A 5-year average of $189.6 million and a median of $196.0 million in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases dropped 3.42% — and 2022, when it jumped 39.01%.
- Year by year, Operating Leases stood at $141.0 million in 2021, then soared by 39.01% to $196.0 million in 2022, then rose by 1.53% to $199.0 million in 2023, then dropped by 1.51% to $196.0 million in 2024, then rose by 10.2% to $216.0 million in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $216.0 million, $196.0 million, and $199.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 216.00 Mn |
| Dec 31, 2024 | 196.00 Mn |
| Dec 31, 2023 | 199.00 Mn |
| Dec 31, 2022 | 196.00 Mn |
| Dec 31, 2021 | 141.00 Mn |
| Dec 31, 2020 | 146.00 Mn |
| Dec 31, 2019 | 170.00 Mn |
| Dec 31, 2018 | 164.00 Mn |
| Dec 31, 2011 | 695.00 Mn |
| Dec 31, 2010 | 727.00 Mn |
| Dec 31, 2009 | 731.00 Mn |